Algert Global’s First Tracks Biotherapeutics TRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAX
Algert Global's TRAX Position: Q3 2026 in Review
Algert Global opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 34,350 shares worth $1.22M. The stake represents 0.01% of the portfolio and ranks #973 among its holdings.
182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.
- Algert Global held 34,350 shares of First Tracks Biotherapeutics worth $1.22M as of Q3 2026.
- First Tracks Biotherapeutics was a new Algert Global position in Q3 2026.
- First Tracks Biotherapeutics made up 0.01% of Algert Global's portfolio in Q3 2026, its #973 holding.
- 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.
Based on Algert Global's 13F filing for Q3 2026, filed 17 Nov 2026.